AspenBio Pharma, Inc.·4

Jan 28, 7:43 PM ET

LANDON JOHN H 4

4 · AspenBio Pharma, Inc. · Filed Jan 28, 2009

Insider Transaction Report

Form 4
Period: 2009-01-27
Transactions
  • Award

    Stock Options

    2009-01-27+50,00050,000 total(indirect: By Trust)
    Exercise: $1.33From: 2009-01-27Exp: 2019-01-27Common Stock (50,000 underlying)
Holdings
  • Stock Options

    (indirect: By Trust)
    Exercise: $5.87From: 2008-12-19Exp: 2018-12-18Common Stock (17,035 underlying)
    17,035
  • Stock Options

    (indirect: By Trust)
    Exercise: $5.87From: 2008-12-19Exp: 2018-12-18Common Stock (50,000 underlying)
    50,000
Footnotes (1)
  • [F1]These options were granted to Mr. Landon pursuant to the Company's 2002 Stock Incentive Plan, and upon grant were assigned to a trust for which Mr. Landon serves as the trustee. The options vest annually on a pro-rata basis over a three year term. This transaction is exempt from Section 16(b) pursuant to Rule 16b-3(d).

Documents

1 file
  • 4
    appy_landon4ex.xmlPrimary